Navigation Links
AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
Date:6/29/2009

>

Study investigator, anesthesiologist Dr. Neil Singla, CEO of Lotus Clinical Research Inc., Pasadena, CA, stated, "The ARX-01 product has the potential to offer a major advance in the management of inpatient acute pain, liberating patients from the IV connection to a PCA pump, while still providing effective pain control appropriate even for patients who are restricted from oral medication. Patients appear to tolerate the Sufentanil NanoTabs well, and following the end of the 12-hour study period when they were switched to IV PCA morphine, many requested that they be returned to study drug. To me, these patients' requests are as demonstrative as any more quantitative endpoint of the product's advantages from the patient perspective."

The current data support the previously reported positive results for ARX-01 from the first Phase 2 study which evaluated the safety and efficacy of ARX-01 Sufentanil NanoTabs in patients undergoing elective unilateral knee replacement surgery. Additionally, an open-label Phase 2 study is currently ongoing with the primary objective of assessing the functionality of the handheld device component of the ARX-01 Sufentanil NanoTab PCA System in patients undergoing unilateral knee replacement surgery.

AcelRx Chief Medical Officer, Pamela Palmer, M.D., Ph.D., commented, "The Phase 2 results from both knee replacement and major abdominal surgery studies demonstrate that a wide variety of patients experiencing moderate-to-severe post-operative pain are able to achieve significant pain relief with our non-invasive approach to patient-controlled analgesia utilizing sublingual Sufentanil NanoTabs. We are pleased with the efficacy results, as well as with the overall side-effect profile of ARX-01 which was indistinguishable from placebo in both studies."

About Acute Post-Operative Pain

Annually, approximately 8 million patients in the U.S. receive intravenous (IV) patient-cont
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
2. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 FDNA® ... analysis will exhibit at the 2014 ASHG meeting, booth ... FDNA will present the latest version of Face2Gene - ... facial analysis technology. Face2Gene facilitates the detection of facial ... facial photos. The new version of Face2Gene ...
(Date:9/23/2014)... HACKENSACK, N.J. , Sept. 23, 2014   ... million in a planned $7 million Series A funding ... participation from Med-Metrix. COTA is the first big data ... outcomes data and cost analysis for cancer care in ... funds will be used to expand development of the ...
(Date:9/23/2014)... 2014 Cerevast Therapeutics Inc., a privately ... of the first interim analysis of its ongoing ... Clotbust ER TM ultrasonic headframe ... independent Data Safety Monitoring Board (DSMB) has recommended ... "Clearing the pre-specified futility threshold and four independent ...
Breaking Medicine Technology:FDNA to Exhibit at ASHG2014 Presenting Face2Gene Integrated With London Medical Databases (LMD) Online 2COTA Closes $3.7M of Planned $7M Series A Funding Round to Transform Cancer Outcomes and Reimbursement 2COTA Closes $3.7M of Planned $7M Series A Funding Round to Transform Cancer Outcomes and Reimbursement 3COTA Closes $3.7M of Planned $7M Series A Funding Round to Transform Cancer Outcomes and Reimbursement 4Cerevast Therapeutics Announces Outcome of First Interim Analysis of Phase 3 CLOTBUSTER Trial for the Treatment of Acute Ischemic Stroke 2Cerevast Therapeutics Announces Outcome of First Interim Analysis of Phase 3 CLOTBUSTER Trial for the Treatment of Acute Ischemic Stroke 3
... May 3, 2012 Valeant Pharmaceuticals International, Inc. ... announced today that Valeant has agreed to acquire ... specialty pharmaceutical company focused on skincare products, for ... attainment of future revenue targets.  University Medical,s main ...
... Medical Group Inc. (Nasdaq: WWIN ) ("Winner ... retailer of high-quality medical dressings and consumer products made ... financial results for its second quarter 2012 on May ... conference call to discuss these results. Date ...
Cached Medicine Technology:Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical 2Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT 2
(Date:9/23/2014)... who are already obese as teenagers could grow up ... peers of normal weight. So says Petter Lundborg of ... Rooth of Linneas University and Lund University, all in ... United Kingdom and the United States, and the results ... , The researchers analyzed large-scale data of 145,193 Swedish-born ...
(Date:9/23/2014)... Vancouver Electrician Contractors, Pro Ace, has recently ... services in Vancouver, BC. The company will provide services ... small maintenance project or a large-scale new installation project, ... the needs of the individual commercial client. Pro Ace ... an affordable price. As a result, businesses of all ...
(Date:9/23/2014)... 2014 The Sloane Clinic™, a ... and Malaysia providing advanced aesthetic dermatology and cosmetic ... its impressive skin care repertoire. Specially formulated with ... against the evil forces of aging, acne and ... this new addition is revolutionizing the way we ...
(Date:9/23/2014)... New York, New York (PRWEB) September 23, 2014 ... move forward in courts around the country, Bernstein Liebhard ... District Court, Middle District of Florida on September 19th, ... claims from a case filed in that jurisdiction on ... breast growth) and other complications due to his use ...
(Date:9/23/2014)... Randy Dotinga HealthDay Reporter ... drugs while in the hospital for a hemorrhagic stroke -- ... four times more likely to survive than people who weren,t ... taking the commonly used drugs known as statins were also ... a rehabilitation facility, the study reports. When it comes ...
Breaking Medicine News(10 mins):Health News:Note to young men: Fat doesn't pay 2Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 3Health News:Cholesterol-Lowering Drugs May Help After Certain Strokes 2Health News:Cholesterol-Lowering Drugs May Help After Certain Strokes 3
... to be under-enrolled in cancer clinical trials, according to a ... CANCER , a peer-reviewed journal of the American Cancer ... to ensure that oncologists know the true effects of treatments ... National Institutes of Health called for clinical trials to include ...
... A local leading ... surgery and what benefits these techniques have for the patient. , ... Manchester, UK (PRWeb UK) 07 June, 2009 -- Cosmetic ... providers of cosmetic surgery than ever before. As a result there is an inherent danger ...
... June 7 There is no difference in mortality among ... received prompt bypass surgery or angioplasty compared to drug therapy ... with both conditions. The study, which was led by investigators ... published in the June 11 issue of the New ...
... ... clinic will be built in Belize City, Belize. , ... Sioux Falls, SD (Vocus) June 7, 2009 -- Children in Central ... today its first international children,s clinic will be built in Belize City, Belize. The new ...
... , NEW ORLEANS, June 6 Catholic health ministry leaders ... Catholic Health Assembly, "In Our Hands: Changing Ourselves, Our Communities, ... the Catholic Health Association of the United States (CHA), is ... across the nation. They come together to share their wisdom, ...
... ... leading organization of plastic surgeons indicates a 162 percent increase in cosmetic surgery since ... with new technologies to treat patients who want to improve their appearance without anyone ... ...
Cached Medicine News:Health News:Women under-represented in most cancer research 2Health News:Latest Developments In Facelift Surgery - Expert Opinion by Mr James Murphy 2Health News:Latest Developments In Facelift Surgery - Expert Opinion by Mr James Murphy 3Health News:Death rates same for diabetes and heart disease patients receiving drug therapy or surgery 2Health News:Sanford Health Announces Sanford Children's Clinic Belize 2Health News:Sanford Health Announces Sanford Children's Clinic Belize 3Health News:Sanford Health Announces Sanford Children's Clinic Belize 4Health News:2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 2Health News:2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 3Health News:Sacramento Plastic Surgeon Charles Perry, MD Embraces Innovative Technologies to Improve Appearance and Self-Esteem 2Health News:Sacramento Plastic Surgeon Charles Perry, MD Embraces Innovative Technologies to Improve Appearance and Self-Esteem 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: